Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000904454-04-000386
Filing Date
2004-06-14
Accepted
2004-06-14 18:22:59
Documents
1
Period of Report
2004-06-10

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 7144
  Complete submission text file 0000904454-04-000386.txt   9088
Mailing Address
Business Address ONE JOHNSON & JOHNSON PLZ NEW BRUNSWICK NJ 08933 7325242454
JOHNSON & JOHNSON (Reporting) CIK: 0000200406 (see all company filings)

State of Incorp.: NJ | Fiscal Year End: 0103
Type: 4 | Act: 34 | File No.: 000-50677 | Film No.: 04862593
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address
JOHNSON & JOHNSON DEVELOPMENT CORP ET AL (Reporting) CIK: 0000924020 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-50677 | Film No.: 04862592

Mailing Address
Business Address 3401 MASONS MILL RD SUITE 100 HUNTINGTON VALLEY PA 19006 215 830 0777 X121
IMMUNICON CORP (Issuer) CIK: 0001083132 (see all company filings)

SIC: 3826 Laboratory Analytical Instruments